Jerrold M. Ward
Impact in
- Cancer Research top 0.05%
- Carcinogens and Genotoxicity Assessment
- Oncology top 0.1%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Peroxisome Proliferator-Activated Receptors 18
- Immunology 92
- Immunotoxicology and immune responses 27
- Co-authors
- Frank J. Gonzalez (36 shared papers)Gilles Lambert (7 shared papers)Pedro M. Fernández‐Salguero (8 shared papers)Shioko Kimura (20 shared papers)Bhalchandra A. Diwan (32 shared papers)Christopher J. Sinal (2 shared papers)Masaaki Miyata (1 shared paper)Masahiro Tohkin (1 shared paper)
- Journals
- Toxicologic Pathology (44 papers)Veterinary Pathology (36 papers)Carcinogenesis (22 papers)Proceedings of the National Academy of Sciences (17 papers)JNCI Journal of the National Cancer Institute (17 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Jerrold M. Ward
476 papers receiving 35.9k citations
Jerrold M. Ward's Hit Papers
Peers
Comparison fields: 5 of 178
- Cancer Research 5.6k
- Oncology 7.2k
- Immunology 5.5k
- Pharmacology 2.1k
- Health, Toxicology and Mutagenesis 3.0k
Countries citing papers authored by Jerrold M. Ward
This map shows the geographic impact of Jerrold M. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerrold M. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerrold M. Ward more than expected).
Fields of papers citing papers by Jerrold M. Ward
This network shows the impact of papers produced by Jerrold M. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerrold M. Ward. The network helps show where Jerrold M. Ward may publish in the future.
Co-authors
The 25 scholars most cited alongside Jerrold M. Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 487 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Hit paper breakdown → | 1993 | 1700 |
| 2 | Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis Hit paper breakdown → | 2000 | 1544 |
| 3 | MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover Hit paper breakdown → | 1999 | 1116 |
| 4 | The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Hit paper breakdown → | 1996 | 1038 |
| 5 | Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis Hit paper breakdown → | 2001 | 943 |
| 6 | Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor Hit paper breakdown → | 1995 | 938 |
| 7 | Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Hit paper breakdown → | 1996 | 804 |
| 8 | Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression Hit paper breakdown → | 2000 | 740 |
| 9 | Aryl-hydrocarbon Receptor-Deficient Mice Are Resistant to 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Toxicity Hit paper breakdown → | 1996 | 728 |
| 10 | Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) Hit paper breakdown → | 2000 | 569 |
| 11 | Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee Hit paper breakdown → | 2004 | 507 |
| 12 | 2003 | 493 | |
| 13 | 2003 | 485 | |
| 14 | 2007 | 483 | |
| 15 | 2010 | 471 | |
| 16 | 2003 | 438 | |
| 17 | 1983 | 414 | |
| 18 | 2000 | 407 | |
| 19 | 1994 | 405 | |
| 20 | 1998 | 389 |
About Jerrold M. Ward
Jerrold M. Ward is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Genetics, having authored 487 papers that have together received 37.5k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (45 papers), Immunotoxicology and immune responses (27 papers), Drug Transport and Resistance Mechanisms (23 papers), Animal testing and alternatives (23 papers), Pharmacogenetics and Drug Metabolism (19 papers), Cancer-related Molecular Pathways (18 papers), Peroxisome Proliferator-Activated Receptors (18 papers) and Heavy Metal Exposure and Toxicity (17 papers). The work is most often cited by research in Cancer Research (5.6k citations), Oncology (7.2k citations), Immunology (5.5k citations), Pharmacology (2.1k citations) and Health, Toxicology and Mutagenesis (3.0k citations). Jerrold M. Ward has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Frank J. Gonzalez, Gilles Lambert, Pedro M. Fernández‐Salguero, Shioko Kimura, Bhalchandra A. Diwan, Christopher J. Sinal, Masaaki Miyata, Masahiro Tohkin, Michael B. Sporn and David M. Hilbert. Their work appears in journals such as Toxicologic Pathology, Veterinary Pathology, Carcinogenesis, Proceedings of the National Academy of Sciences and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.